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ABSTRACT
The American University in Cairo

Transcriptional Regulatory Networks in Hepatitis C Virus-induced
Hepatocellular Carcinoma
By: Marwa Zahra
Under the Supervision of: Dr. Hassan Azzazy & Dr. Ahmed Moustafa
HCV is an epidemic affecting an estimated 160 million individuals worldwide or approximately
2.35% of the world’s population.(1) This is partly because HCV exhibits high genetic variation
which thereby characterizes each region with its own genetic prevalence. Therefore,
understanding the transcriptional regulatory elements that influence the progression of liver
disease in the presence of HCV infection is thereby crucial for diagnostic and therapeutic
purposes. Systems biology provides a road map by which these elements may be easily
identified. In this study 124 microarray samples were assessed in order to determine
differentially expressed genes for 4 tissue types/conditions (normal, cirrhosis, cirrhosis HCC, and
HCC). Differentially expressed genes were assessed for their functional clustering and those
genes were annotated with their potential transcription factors and miRNAs. Transcriptional
regulatory networks were constructed to visualize each pairwise comparison between the 4 tissue
types/conditions. In this study that 12 transcription factors were found to have high expression
patterns amongst all 6 pairwise comparisons and these transcription factors also provide insight
the conditions of the liver as it progresses through hepatic cirrhosis, hepatic steatosis, and the
induction of cancer. With the plethora of miRNAs that are found in the liver, each liver condition
was found to have its own signature miRNA expression pattern. In the 6 pairwise comparisons
14 miRNAs were found to have high expression patterns in all 6 pairwise comparisons and their
regulation in HCC was determined as well as their impact on cellular homeostasis. Based on the
findings of this study and a systematic analysis of many studies it can be concluded that as the
liver progresses from cirrhosis to steatosis and eventually becoming carcinomic there are specific
transcription factors regulating this transition through each stage. Whereas the condition of the
liver digresses, the downregulation of miRNAs’ expression makes the transition of the liver
through each pathological stage more apparent. Therefore, an understanding of the
transcriptional regulatory attributes acts as a road map to provide interference strategies in order
to target the stages in the progression of HCV induced HCC.
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Chapter 1. Introduction
I.

HCV
a. Epidemiology

HCV is an epidemic affecting an estimated 160 million individuals worldwide or approximately
2.35% of the world’s population. (1) This is partly because HCV exhibits high genetic variation
which thereby characterizes each region with its own genetic prevalence. How HCV affects
every area in the world is specific to the genotype of HCV that is prevalent in that area. HCV
strains are classified into seven genotypes (1-7) based on phylogenetic and sequence analyses of
whole viral genomes.(2)Within each genotype, HCV is classified into 67 confirmed and 20
provisional subtypes. Strains that belong to the same subtype differ at <15% of nucleotide
sites.(3)
The geographic distribution of HCV genotypes is very complex. HCV genotype 1 is the most
prevalent worldwide, comprising 83.4 million cases (46.2% of all HCV cases). Approximately
one-third of those cases are in East Asia alone. Genotype 3 is the next most prevalent globally
comprising 30.1% of all cases and 54.3 million cases. While genotypes 2, 4, and 6, are
responsible for a total 22.8% of all cases of HCV globally. Finally, genotype 5 comprises the
remaining <1% of cases globally. Although genotypes 1 and 3 dominate in most countries
irrespective of economic status, the largest proportions of genotypes 4 and 5 are in lower-income
countries. (4)
While HCV exhibits high genetic variation as well as a rapid reproduction rate the reason as to
how this virus has become an epidemic lies not in the lethality of the virus rather in the manner
of its transmission. Blood transfusions, injection drug use, use of contaminated glass syringes, as
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well as nosocomial infections are the main ways behind HCV transmission. Latin American
countries have been very active in screening blood supplies, thus minimizing the risk of
transmission through transfusion. (1) However, as in most western countries, other risk factors
are currently playing a major role in accounting for new infections. The main risk for HCV
transmission in countries with well-established HCV screening programs and lower HCV
prevalence was found to be injection drug use.
Also, immigration from endemic countries was sometimes a major factor impacting the total
number of HCV-infected persons: approximately 70% of cases in Israel, 37% in Germany and
33% in Switzerland were not born in the country. These data express the high heterogeneity of
HCV across Europe, Canada and Israel. While most countries had prevalence rates of HCV cases
from 1 to 2%, several other countries presented relatively high prevalence rates, such as Egypt
(15%), Pakistan (4.7%) and Taiwan (4.4%). (1) Nosocomial infections and injection drug use are
major risk factors in the region, and in some countries blood donors are still not universally
screened. These regions are in desperate need of effective health policies that are watched over
by stringent surveillance systems in order to control the spread of HCV.
Due to aging of the current HCV-infected population, the problem of hepatitis C is expected to
increase. A study from USA has shown that aging of the HCV infected population has already
resulted in a signiﬁcant increase in the prevalence of cirrhosis and hepatocellular carcinoma
(HCC) cases reported in that country during the period 1996–2006. According to another work
from the same country, the number of HCV-related cirrhosis cases is estimated to increase by
24% and that of decompensated cirrhosis cases by 50%. (5) Also, a synergistic effect on
morbidity and mortality is anticipated due to the overlapping worldwide epidemics of HCV,
therefore the above estimates should be considered conservative.
12

b. HCV in Egypt
In Egypt, the spread of HCV stems from the outbreak of blood flukes that cause schistosomiasis.
In the 1920s, in an attempt to treat the schistosomiasis outbreak with injection of potassium
antimony tartrate through a mass inoculation campaign; the world’s largest iatrogenic spread of
blood-borne pathogen was created. Millions of intravenous injections were given with
inadequately sterilized equipment which caused the spread of HCV. (6)
Today Egypt has a HCV epidemic, which is the largest HCV epidemic in the world. The most
common variant of HCV in Egypt, genotype 4, has the highest pravelence and accounts for more
than 90% of infections. (7) Given a national population of about 80 million persons, 7.8 million
were estimated to be asymptomatically infected with HCV comprising a large reservoir of HCV
in the population. The Egyptian demographic health survey in 2008, estimated HCV prevalence
among the 15–59 years age group to be 14.7%. (8)
In order to evaluate the magnitude and patterns of exposure to HCV transmission
epidemiological tools are needed. Also, for intervention to reduce HCV infection in Egypt,
factors related to the distribution and determinates of HCV exposure must be evaluated.(9)
c. HCV Infection
HCV is a member of the Flaviviridae family, and is comprised of a single-stranded RNA genome
9.6 Kb in size and positive polarity. HCV has an error-prone RNA-dependent RNA polymerase
that produces a highly variable progeny. This error-prone replication has allowed for an original
HCV ancestor to evolve into seven genotypes and more than 80 subtypes due to the nucleotide
variation that is among different HCV isolates (10). Also, due to the high mutation rate each
infected individual has a collection of distinct but related HCV genomes generated by
replication, known as quasi-species (11).
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HCV viral particle is 40-80 nm in size. Viral particles are enveloped and contain their genetic
material bound to the core protein (12). The viral genome is a positive stranded RNA that serves
as a messenger RNA. The open reading frame is flanked by highly structured untranslated
regions (UTR) that contain several domains important for viral replication. These domains are
fairly well conserved compared to the rest of the genome, thus supporting their importance in
viral fitness (13).The open reading frame encodes a polyprotein cleaved co- and posttranscriptionally by viral and cellular proteases into the three major structural proteins (core, E1
and E2) and seven non-structural proteins (p7, NS2, NS3, NS4A, NS4B, NS5A and NS5B).
The viral particle is formed by the two envelope glycoproteins, E1 and E2, required for cell
attachment and entry, and by the core capsid protein. P7, forms an ion-channel and participates
in virus assembly and in the release of infectious virions (14). NS2 autoprotease also participates
in virus assembly and might affect replication indirectly, as the cleavage at the NS2/NS3
junction seems to be a rate limiting step and a fully processed NS3 protein is required for
replication. NS3, NS4A, NS4B, NS5A and NS5B form the replicase complex. The viral
helicase/protease NS3, has an essential role in the processing of the non-structural proteins and
of some host cellular proteins (14). NS4A is a cofactor that leads NS3 to the endoplasmic
reticulum (ER) it also increases NS3 stability and protease and helicase activity. NS4B is
involved in packaging the virus and also participates in membrane remodeling. NS5A is
multifunctional in that it induces the formation of a membranous web, is involved in replication
and in viral assembly, and affects the antiviral response (15). NS5B is the RNA dependent RNA
polymerase required for replication and HCV assembly (16).
d. HCV Replication
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In the blood, HCV virions circulate as lipo-viro-particles (LVPs) which are found to be
associated with very low or low-density lipoproteins (VLDLs and LDLs). These LVPs may also
associate with high levels of triglycerides, Apolipoprotein (Apo) E, ApoC, ApoB and low levels
of cholesterol or phospholipids (17). This HCV virion association with lipids may facilitate its
infection of hepatocytes which are the primary target for infection while at the same time aiding
in its escape from neutralizing antibodies.
The exact mechanism of viral entry is still unclear entry occurs very likely by clathrin-mediated
endocytosis (18). It has been suggested that the viral envelope proteins E1 and E2 bind different
cellular proteins identified as receptors for viral entry such as scavenger receptor class B type 1
(SRB1) and CD81 (19). Also required for entry are the tight junction proteins claudin-1
(CLDN1) and occludin (OCLN), the epidermal growth factor receptor (EGFR) and the NiemannPick C1-like cholesterol absorption protein (NPC1L1), which may bind to virion-associated
cholesterol at a late stage of HCV entry (20).
Once inside acidification of the endosome induces fusion of the viral envelope so that the virion
undergoes un-coating. This fusion between the endosome and virion envelope leads to the
release of the viral RNA into the cytoplasm. In the cytoplasm the viral RNA is transported to the
rough ER for translation of the viral polyprotein; which is then further processed into the
structural and non-structural proteins. HCV replicates in association with a specialized
membrane structure named membranous web (MW), formed by double-membrane vesicles (21).
The remaining components of the replication complex alongside the actions of NS4B and NS5A
are the key players in the formation of the MW. NS5B which is the viral RNA dependent RNA
polymerase, uses the viral genome as a template to produce negative-strand RNA intermediates.
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These intermediates are then amplified to large amounts of new positive-strand RNA viral
genomes.
Assembly of HCV virion is brought about by the synchronized actions of HCV structural
proteins along with the viral replication complex, and takes place in close proximity to
membrane bound lipid droplets (LD). Lipid droplets (LDs) are intracellular organelles storing
cholesterol and triglycerides, and play an essential role in viral packaging. Inhibition of the
synthesis of their lipid components blocks viral assembly. NS5A, as part of the replication
complex, connects virus replication and packaging. New virus particles are bound to VLDL or
LDL components and use the secretory pathway to be released as LVPs (22). Thus, HCV release
is intimately associated with the synthesis of VLDLs and the lipid secretion pathway (17). Once
released, LVPs can infect new host cells.
e. HCV and Interferon
The IFN-mediated innate immune response protects the cell against infection. Upon viral
infection, several viral features or pathogen-associated molecular patterns (PAMPs) are detected
by canonical or non-canonical receptors located on the cell membrane or intracellularly.
Canonical receptors are receptors such as the retinoic acid-inducible gene I (RIG-I) or the
Melanoma Differentiation-Associated protein 5 (MDA5) (23). In HCV for example, RIG-I can
recognize the RNA genome within hours of infection and may initiate signaling before extensive
viral protein synthesis takes place (24).
HCV can also be sensed by non-canonical receptor, protein kinase R (PKR) and DEAD box
helicase DDX3X which are able to induce expression of antiviral genes. The first HCV sensor
protein kinase R (PKR) is a kinase that is phosphorylated and activated by dsRNA binding and
recognizes the 5´UTR of the HCV genome (25). The DEAD box helicase DDX3X, recognizes
16

3´UTR of HCV genome. DDX3X is a multifunctional protein involved in immune response
activation (25). Although both PKR and DDX3X are antiviral, both are required for efficient
HCV replication (26).
The activation of the Interferon regulatory factor (IRF) 3 and nuclear factor-κΒ (NF-κΒ) are
independent of the sensors that initiate cascades for canonical and non-canonical receptors (25).
IRF3 induces the expression of some IFN stimulated genes (ISGs), NF-κΒ induces proinflammatory cytokines and together, IRF3 and NF-κΒ serve to induce transcription of IFNβ.
Then, the signaling that is initiated by IFNβ leads to upregulation of IRF7, which, together with
IRF3, can lead to the synthesis of several IFN subtypes (25).
IFNλ signaling has a special impact on HCV infection in that several single nucleotide
polymorphisms within the IFNλ loci associate strongly with the natural clearance of HCV
infection and with response to IFNα-based antiviral therapy (27). Several ISGs function to
induce an antiviral state that affects HCV infection; such as STAT1, STAT2, IRF1, 3, 7 and 9,
PKR, OAS or RNase L which work to increase cell sensitivity to PAMPs. These in turn function
as positive regulators to reinforce IFN signaling and prime cells for enhanced pathogen
detection. For example IRF1, a transcription factor that induces a secondary wave of ISG
transcription probably evolved to maintain an antiviral state after pathogen-mediated inhibition
of the first wave of IFN response (28).
It becomes apparent as the role of ISGs as antivirals and positive regulators of the IFN response,
that IFN is able to eliminate HCV infection. IFN therapy has been used in the treatment of HCV
infected patients until very recently as treatment by overexpression of specific ISGs is not
efficient.
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This combined action of several ISGs causes a strong inhibition of HCV, rather than the single
action of any one of several ISGs has lead HCV to counteract the antiviral role of the IFN
response, and has evolved to block IFN induction and interfere with the action of several
antiviral factors. The viral NS3-NS4A protease, which is a key component in the HCV innate
immune evasion cleaves and inactivates MAVS and TRIF, interfering with the signaling of the
major HCV sensors and attenuating IFN production (29). NS4A/B precursor then inhibits the
transport of MHC Class I molecules to the cell surface. NS5A and the core proteins block the
STAT pathway by several means (25). .
HCV has also evolved to exploit the expression of ISGs. ISGs function as negative regulators of
the IFN response; since, viruses use many cellular systems, when the antiviral response affects
the machineries required for viral viability; it compromises its own integrity. Yet, once IFN
responses wear out it leads to autoimmune disorders (30). Therefore, the cell has evolved to
express some ISGs that function as negative regulators of the IFN pathway which are essential to
limiting the duration and strength of the IFN response and aid the cell back to homeostasis.

II.

Liver Disease and HCV

At the onset of HCV infection the liver begins to react to the virus in many ways. As the virus
begins to replicate and the liver sends signals to ISGs to react to these new particles in the body;
the stage begins to set for changes to in the liver. HCV may have no effect on some livers,
however for the majority of cases HCV digresses the condition of the liver in stages. These
stages include the digression from cirrhosis, to steatosis, and eventually carcinoma. Clinical
symptoms or signs of liver disease may or may not appear and a minority of patients experience
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clinical symptoms. However, symptoms that do accompany liver disease include fatigue nausea,
poor appetite, muscle aches, arthralgias, feverishness, weakness, and weight loss. Aside from
symptoms, the majority of patients with HCV are recognized by having raised ALT serum levels.
Again, a minority of patients may not have elevated ALT levels and these patients may be
described as “healthy carriers”. Studies have shown however that prolonged elevated ALT levels
are associated with the development of cirrhosis in the liver. (31)

Figure 1: HCV infection and the progression of liver disease. Here it becomes apparent that with the right conditions liver
disease progresses to HCC over a period of time. Although this is not a central dogma of liver disease, progression to HCC may
proceed in this manner if all of the conditions shown are present.(32)

Chronic HCV can lead to cirrhosis which can develop rapidly; within 1–2 years of exposure, or
slowly within 2–3 decades. In studies with 10–20 years of follow-up, cirrhosis develops in 20–30
percent of patients. Once cirrhosis develops symptoms of end-stage liver disease can appear.
These symptoms are marked by fatigue, muscle weakness and wasting, fluid retention, easy
bruisability, upper intestinal hemorrhage, jaundice, dark urine, and itching. Yet, some patients
with cirrhosis remain asymptomatic of liver disease until they have major complications of
cirrhosis, such as variceal hemorrhage or ascites or they die of an unrelated cause. (31)
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Another condition that can hasten the development of cirrhosis in the liver and lead to the
progression of end-stage liver disease in the presence of HCV infection is hepatic steatosis.
Hepatic steatosis is defined as excessive lipid accumulation within the hepatocyte cytoplasm and
has been recognized as the sole route for a direct cytopathic effect by the HCV. Several
mechanisms have been proposed as to the process of lipid accumulation in the liver such as;
HCV core protein may be interacting with apolipoprotein. AII which is a major component of
high density lipoproteins and this interaction may be causing hepatocellular steatosis.(33) Also, it
has been suggested that the HCV core protein induces oxidative stress within the mitochondria
which leads to or contributes to lipid accumulation.(34) Yet, in the retrospect it is important to
note that hepatic steatosis leads to the progression of end-stage liver disease, whether steatosis
achieves this by aggravating fibrosis itself or the factors that are causing steatosis are also
aggravating fibrosis is still unknown.
It is important to note that while IFN treatment may reduce the incidence of HCC. HCC is an
inevitable event as the liver digresses in its condition by steatosis and cirrhosis. The mechanism
by which this eventual digression leads to carcinoma is still unknown. However, through
analysis of the key components that lead to the progression of liver disease to carcinoma it is
apparent that the condition of the liver is at large the reason behind the incapability of the liver to
maintain cellular homeostasis and in turn eventually digresses to carcinoma.

III. HCV induced Hepatocellular Carcinoma
a. Pathogenesis
The development of HCV-induced HCC is progressive and may occur over a period of 20-40
years. This multi-step progression involves establishment of chronic HCV infection, chronic
hepatic inflammation, progressive liver fibrosis, initiation of neoplastic clones accompanied by
20

irreversible somatic genetic/epigenetic alterations, and progression of the malignant clones in a
carcinogenic tissue microenvironment. Yet, each step of HCV-induced hepato-carcinogenesis is
a potential target for therapeutic intervention or chemoprevention. Since, HCV is a RNA virus
with limited integration of its genetic material into the host’s genome, the carcinogenic potential
of HCV is generally assumed to be linked to indirect mechanisms. A major obstacle for the
understanding of the mechanisms linking HCV infection, inflammation and carcinogenesis is the
lack of an in vitro and in vivo model systems. (35)
b. Host factors affecting Susceptibility
There have been associations made between various host polymorphisms associated with the
immune system and HCV-induced HCC. A Japanese genome-wide association study comparing
HCV-related HCC patients with chronic hepatitis C patients identified a single nucleotide
polymorphism (SNP) in MHC class I polypeptide-related sequence A (MICA - rs2596542),
which is involved in response of dendritic cells to type-I interferon in chronic hepatitis C (36).
Another SNP in the MICA promoter (rs2596538) was associated with increased serum soluble
MICA protein. In another study, in Caucasian HCV patients in Switzerland did not replicate the
association with HCC for this locus, but for a nearby locus in HCP5 (rs2244546), suggesting that
the MICA/HCP5 region contains a potential susceptibility locus.(37) An IL28B variant
(rs12979860), initially identified as an interferon response predictor, may be associated with
increased risk of HCV-related HCC (38).

Also, SNPs in genes associated with metabolic functions have also been weakly associated with
HCV-induced HCC. In patients with chronic HCV with advanced fibrosis a positive association
has been found between liver iron deposition and higher incidence of HCC (35). Also, a SNP in
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the patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene (rs738409) associated with alcoholic and non-alcoholic steatohepatitis may have weak association with HCV-related
HCC (35, 39).
c. Assessment of Risk: HCV-induced HCC
Due to the high prevalence of HCV-induced cirrhosis and the population that is at risk of
developing HCC, the need for surveillance is essential, and yet probably unmanageable. For
instance, despite guidelines recommending HCC surveillance in subjects with cirrhosis, most
patients at risk of HCC in the US do not receive recommended regular surveillance. Only 12% of
cirrhotic HCV patients had routine annual surveillance in one US Veterans Affairs series and
only 2% of HCV patients who developed HCC had previous appropriate screening in another series. Also, in a population-based US study, less than 20% of patients with cirrhosis who
developed HCC received regular surveillance. (35)
This thereby expresses the need for prognostic indicators that would actively stratify HCV
subjects, as well as patients with other liver diseases, into clearly defined risk groups to enable
effective clinical management of patients (40).

IV. Transcriptional Regulation
The regulation of transcription is the means by which the cell facilitates the regulation of DNA to RNA in
order to orchestrate gene activity. The attributes that aid in this facilitation are transcription factors and
miRNAs. These attributes fine tune the rate of gene regulation and in turn affect overall transcription
regulation.

a. Transcription Factors
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Transcription factors include a wide number of proteins that regulate the transcription of genes.
These, transcription factors, are proteins that are involved in the converting or transcribing DNA
into RNA. Transcription factors have DNA-binding domains that allow them to bind to specific
sequences of DNA.(41) Those transcription factors with promoter sequences bind to a DNA
promoter sequence near the transcription start site and help form the transcription initiation
complex. (42)While, other transcription factors bind to regulatory sequences, such as enhancer
sequences and can stimulate or repress transcription of the related gene. (42) The action of
transcription factors allows for unique expression of each gene in different cell types and during
development.
b. miRNAs

MicroRNAs act to fine-tune the expression of as much as 30% of all mammalian proteinencoding genes. Mature miRNAs are short, approximately 22 nucleotides in length, and singlestranded RNA molecules.(43) Their diverse expression patterns allow them to regulate many
aspects of development and physiology.(44)
While the majority of the characterized miRNA genes are intergenic, or oriented antisense to
neighboring genes and are therefore transcribed as independent units. A miRNA gene may also
be transcribed together with its host gene, which provides a means for coupled regulation of
miRNA and protein-coding gene.(45)
As much as 40% of miRNA genes may lie in the introns of protein and non-protein coding genes
or even in exons of long nonprotein-coding transcripts.(46) These are found in a sense
orientation, and thus usually are regulated together with their host genes. Other miRNA genes
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with a common promoter include the 42-48% of all miRNAs originating from polycistronic
units. (46)
The DNA template is not the final word on mature miRNA production: 6% of human miRNAs
show RNA editing (IsomiRs), the site-specific modification of RNA sequences to yield products
different from those encoded by their DNA.(47) This increases the diversity and scope of
miRNA action beyond that implicated from the genome alone.

V.

Microarray Analysis

Genes in biology are studied in many ways and analyzed through many perspectives, one of the
most indispensable tools that biologists use to monitor gene levels in a given organism. A
microarray is a glass slide on to which DNA molecules are fixed at specific locations called
spots; each spot may contain copies of identical DNA molecules that uniquely correspond to a
gene(48). This DNA may either be genomic or a short stretch of oligo-nucleotide strands that
correspond to a gene.
Microarrays are manipulated in a variety of ways in order to measure gene expression. One of
the most popular methods used is a means of comparison between a set of genes from a cell in a
particular condition to the same set of genes in a reference cell under normal conditions. This is
done by extracting RNA from these cells and converting it into cDNA using reverse transcriptase
and nucleotides labelled with different fluorescent dyes. These dyes allow for samples to be
differentially labeled. These samples then are allowed to hybridize onto the same glass slide
where they will bind to specific spots on the glass slide containing its complementary sequences.
Spots on the hybridized microarray are then excited by a laser and scanned at wavelengths
suitable to the dyes used. The fluorescence that is emitted corresponds to the concentration of
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bound nucleic acid, and the final image of the microarray is a spot that corresponds to a gene
with an associated fluorescence value expressing the relative expression level of that gene. (48)
a. Data Analysis
There are many sources of systematic variations that may affect gene expression levels.
Variation may arise from differential labeling efficiency of fluorescent dyes, or different amount
of starting mRNA in the two samples. In order to eliminate variations and allow for a honed
comparison of data from two samples the data that is obtained is normalized. Normalization is
performed by choosing a gene-set for which expression levels should not change under the
conditions studied. That gene set is expected to be 1, and any variability that is seen in other
gene- sets is calculated based on its deviation. This normalization thus preserves biological
variations and minimizes experimental variations. Several algorithms may also be called upon in
order to achieve normalization; these include robust microarray analysis (RMA), GC-RMA as
well as Microarray Analysis Suite (MAS5.0). These algorithms only differ in their way of
background correction, scaling and calculation of the normalization factor.(49)
b. Determining Biological Relevance
Once data has been normalized it may be inspected for biologically significant variations that are
statistically significant. A fold change value is the means by which biological significance is
displayed. This fold change value is calculated as the ratio between the log expression intensity
of a certain gene compared to its normal condition expression value. The higher this value, is the
greater the biological significance. However, statistical significance for a data set is determined
by another value the p-value; which is defined as the probability of accepting the NULL
hypothesis when it should be rejected. The higher this value the less the data is statistically
significant. These statistical tests when applied provide a set of genes that are differentially
expressed (DE). These genes are of particular interest in that they show biological and statistical
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significance across all experimental conditions and in turn express a strong over expression or
down expression compared to their controls.(50) From this inferences can be made as to
relationships between genes and their regulation in general.
Data from microarray analysis or gene expression data can be used to infer regulatory
relationships. Studies have showed that expression data may be used as a tool to make
predictions about transcriptional regulators for a given gene or for a gene set as well as
identifying modules of co-regulated genes and their transcriptional regulators by means of a
probabilistic model. This allows for further hypothesis to be made which are experimentally
testable. (51)

VI. Systems Approach
The systems approach to biology is centralized around one particular theme which is the sum of
the whole is greater than the sum of its parts. Since, the central dogma in biology is DNA to
RNA to protein; it makes sense that one would approach a biological question in this manner,
since no one of the pieces in the central dogma is enough to answer a biological question fully.
Systems biology or the systems approach, studies biological systems by systematically breaking
them down and looking at the gene, protein, and informational pathway responses. The
integration of this data by means of mathematical models ultimately describes the structure of the
system, and in turn answers questions that may arise to any disruptions that may happen to that
system. (52)
New technologies for systematically characterizing cellular responses have brought about this
new approach to understanding biological systems. Tools such as DNA sequencers, microarrays,
and high-throughput proteomics have become the methods of choice for rapid and
comprehensive assessment of biological system properties and dynamics. Microarrays are a
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powerful tool that allows interrogation of complete human transcriptomes. Microarrays make it
possible to distinguish single nucleotide differences and in turn add even the most miniscule
details to the whole system. This increases the capacity for a suitable diagnostic approach to
many diseases and a more refined method for approaching suitable treatment.
Approaching a disease such as HCV using a systems approach is most effective, in that it is a
very robust disease that attacks biological systems through many attributes. Especially when
considering HCV as it induces HCC, this approach becomes most suitable as it looks, not only at
the gene-gene interactions involved but also at the regulatory aspects of those genes. This allows
for the construction of transcription regulatory networks which takes into account all the
regulatory elements that impress on a particular gene of interest. In these networks, transcription
factors’ (TFs) databases such as TRANSFAC, JASPAR, and SWISSREGULON are utilized to
obtain information about the binding motif sites related to these TFs, as well as the potential
interacting genes. Also, understanding how HCV affects biological systems would not be
complete without considering miRNAs. miRNAs are known to regulate gene transcription via
the interaction with mRNA. Over 2500 mature human miRNA have been isolated and described
in a public database known as miRBase.(52) Therefore, understanding the changes in gene
transcription regulated by miRNAs and provoked by HCV may explain causes for fibrosis and
carcinoma in liver tissues.
In order to visualize all of the aspects that contribute to the regulation of a biological system
Cytoscape 3.2.1 is utilized. Cytoscape is an open source software platform that allows for
visualization of complex networks while at the same time integrating any data attributes to that
network. This in turn allows for the visualization of a network as a whole system with all of the
parts that may be involved in its regulation.
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Since, HCV attacks the liver in a manner that disrupts its normal functioning, it is only feasible
that in order to attack back at such a disease, that a clear picture must be drawn as to where, in
the regulation of normal functioning, this disruption takes place. Accordingly, this thesis places
an emphasis on the study of the interactions that take place in the transcription regulation that
alters gene expression in HCV induced HCC.
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Chapter 2. Hypothesis and Objectives
HCV has always been studied in a manner that examines a specific attribute that is affected by
infection. In this study, HCV is analyzed based on how it affects transcription regulation as a
whole and eventually leads to Hepatocellular Carcinoma. In this study it is hypothesized that:
Each tissue type or condition has a variable gene expression profile that determines its signature
transcriptional regulatory network and therefore infers possible factors that influence HCVinduced HCC.

OBJECTIVE 1

In this study our aim is to be able to determine first differentially expressed genes in 6 pairwise
comparisons in order to be able to determine those genes that are influenced by HCV induced
HCC.

OBJECTIVE 2

After determining those genes that are differentially expressed in each of the 6 groups,
transcription factors and miRNAs associated with the regulation of those genes are to be
determined and analyzed for their association with those genes.

OBJECTIVE 3

Once, the transcription regulators for the differentially expressed genes in each of the 6 groups
have been determined, a network will be constructed in order to visualize the attributes that
transcriptionally regulate the differentially expressed genes in each group.
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Chapter 3. Materials and Methods
Study design
In order to study transcription regulation, first, the differential expression in each of the four
sample clusters (normal, cirrhosis, cirrhosis with HCC, and HCC) were compared against one
another, using R studio, and 6 groups were obtained:
Group 1: Normal_ Cirrhosis; which compares normal mean expression values for differentially
expressed genes against cirrhosis mean expression values for differentially expressed genes.
Group 2: Normal_Cirrhosis HCC; which compares normal mean expression values for
differentially expressed genes against cirrhosis HCC mean expression values for differentially
expressed genes
Group 3: Normal_HCC; which compares normal mean expression values for differentially
expressed genes against HCC mean expression values for differentially expressed genes.
Group 4: Cirrhosis _Cirrhosis HCC; which compares cirrhosis mean expression values for
differentially expressed genes against cirrhosis with HCC mean expression values for
differentially expressed genes.
Group 5: Cirrhosis _ HCC; which compares cirrhosis mean expression values for differentially
expressed genes against HCC mean expression values for differentially expressed genes.
Group 6: Cirrhosis HCC _ HCC; which compares cirrhosis with HCC mean expression values
for differentially expressed genes against HCC mean expression values for differentially
expressed genes.
After the differentially expressed genes were determined, these genes were annotated with their
transcription factors and miRNAs in tables accessible to Cytoscape. The transcription regulatory
networks obtained from Cytoscape were studied with reference to the literature.

Softwares employed:
In this study several softwares were employed. In order to attain microarray samples GEO which
is a public functional genomics data repository supporting MIAME-compliant data submissions
was employed. Within GEO array- and sequence-based data are accepted and tools are provided
to help users query and download experiments and curated gene expression profiles. Once
microarray data was provided R studio was employed in order to process microarray data for
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further analysis. R studio is a free open source integrated development environment which
utilizes a programming language for statistical computing and graphics. Visualization of
transcriptional networks was performed using the software Cytoscape 3.2.1. which is an open
source software platform for visualizing complex networks and integrating them with any type of
attribute data. Finally, database for annotation visualization and integrated discovery (DAVID)
was employed. DAVID is a bioinformatics tool that provides a comprehensive set of functional
annotation tools for investigators to understand biological meaning behind large list of genes.

Samples
The samples that were used in this study were obtained from a previous study, “Genes
involved in viral carcinogenesis and tumor initiation in Hepatitis C virus- induced Hepatocellular
Carcinoma” performed by the group of Mas V., etal. 2009. The samples corresponding to this
study were obtained from the Gene Expression Omnibus (GEO) with the identification number
GSE14323. From this database 124 samples were obtained and downloaded in the form of a
compressed file 500MB in size. These samples were then extracted and prepared for further
processing in the form of .cel files.

Sample Characteristics
The study that was used was restricted to patients with HCV infection. These samples
included 124 liver tissue samples obtained from 88 distinct patients, 41 HCV-cirrhotic from
patients without HCC, 17 cirrhotic tissues from patients with HCC, and 47 HCV-HCC tissues.
Also, 13 patients with HCC-cirrhosis provided both tumor and cirrhotic tissue, 3 patients
provided both cirrhotic or tumor tissue for array processing, and 19 normal liver tissues were
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included. These patients were found to have normal liver function and histopathology, as well as
the normal liver samples used which were also seronegative for HCV Ab.

Sample Processing: R studio
The samples that were obtained were further processed using R version 3.2.0. Samples in
the form of .cel files were found to be in two different affymetrix platforms because of the
difference in probes used for the samples. Therefore, in R studio an affy bioconductor package
was downloaded to read the samples in the form of .cel files and samples were separated into
DATA1 and DATA2 based on the Affymetrix platform corresponding to the samples. DATA1 in
R corresponded to samples GSM358107- GSM358111, while DATA2 corresponded to samples
GSM358112- GSM358227. These samples were converted from .cel files which are files that
correspond to light intensities into .cdf files that converted light intensities into probe
concentrations using the affy Bioconductor package in R studio. After which these values were
then converted into expression values using the Robust Multiarray Average (RMA). These
expression values were then saved for further processing.

Sample Processing: Determination of Differential Expression
In order to be able to analyze the dataset for differentially expressed genes, the samples
were further analyzed using R version 3.2.0. Since this study contained 124 samples, these
samples were grouped into 4 matrices, normal, cirrhosis, cirrhosis HCC, and carcinoma. The
mean of the expression values was determined for the samples in each group and written into a
new table with the probe ID beside it. A scatter plot was then created for groups against one
another to show if there was differential expression. In order to test samples for biological and
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statistical significance, the samples were filtered by a fold cut off of 2 and a p-value of 0.01. A
volcano plot was then created in order to show biological and statistical significance.
Genes that were found to be both biologically and statistically significant from the
volcano plot were filtered into a table by themselves based on the fold cutoff and p-value that
were used as a criterion for filtration case by case. A logical vector was created in order to filter
these genes and the fold cut off and p-value that was applicable for each case was setup in this
vector in order for genes that were found to be true and true for both values were placed into this
vector and written into a table.
In order to show the distance or similarity between groups after the filtered differentially
expressed genes were written into each group a column dendogram was created. Row
dendograms were also created in order to show similarity between differentially expressed genes
in each case. A heat map was also created in order to visualize the differentially expressed genes
across each group with yellow, corresponding to high expression, and red, corresponding to low
expression.
Once the differentially expressed genes were determined for each case, they were
manually paired with their corresponding transcription factors and miRNAs. Using various
databases such as TRANSFAC, miRBASE, and GENECARDS, transcription factors and
miRNAs were searched for in order to correspond to genes that were determined to be
differentially expressed. These results were then written into a table in the form of a text file and
were further processed.

Systems Approach: Networks
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Tables that were created with differentially expressed genes and their corresponding
transcription factors and miRNAs were evaluated using Cytoscape version 3.2.1. Tables were
imported in the form of text files and a network was created in order to visualize the structure of
how the genes are connected to their transcription factors and miRNAs. In each network genes
are colored in blue, transcription factors are in green, and miRNAs are in red. The size of genes
corresponded to their fold change, and each network was analyzed and clusters were determined
if any.
Differentially expressed genes were also functionally annotated using DAVID database.
This database clustered genes in each case based on their function. Genes were delivered to the
database in the form of a list, case by case, and the database clustered the list of genes based on
the similarity of the genes functionally.
Table 1: Summary of databases employed for analysis in this study. For each database that was employed a reference is given as
a hyperlink by which this database may be accessed.

Database
Gene Expression Omnibus (GEO)
DAVID
TRANSFAC
MirBASE
GENECARDS

Reference
www.ncbi.nlm.nih.gov/geo
https://david.ncifcrf.gov/
www.gene-regulation.com/pub/databases.html
www.mirbase.org
www.genecards.org
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Figure 2: Schematic display of study design. As an overview of how this study was performed this diagram shows the process
that the study proceeded in to create transcriptional regulatory networks for HCV-induced HCC.
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Chapter 4. Results
The samples in this study were obtained from the Gene Expression Omnibus (GEO) with the
identification number GSE14323. The samples were broken down as shown in Figure 3, 124
samples were obtained and analyzed using R studio in order to determine differential expression
of genes in each of the 4 distinct samples’ clusters.

Total Number of
Samples: 124

19 Normal
Samples
41 HCV-Cirrhosis
Samples without
HCC

17 HCV-Cirrhosis
Samples with
HCC

47 HCV-HCC
Samples

Figure 3: Diagram of the samples obtained for this study from GEO (GSE14323). A total of 124 samples were obtained; as 19
normal samples, 41 HCV-cirrhosis samples without HCC, 17 HCV-cirrhosis samples with HCC, and 47 HCV-HCC samples.
These samples were further analyzed using Affymetrix microarray analysis.

The means of the expression values for differentially expressed genes in each of the four sample
clusters were placed into matrices so that they may be correlated against one another as shown in
figure 3, the column dendogram.
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Figure 4: Column dendogram showing the correlation between the mean expression values of the genes in each of the 4 samples’
clusters. The greater the value on the y-axis the lower the correlation between the groups, as is apparent the highest correlation is
between cirrhosis and cirrhosis HCC.

As the value in the y-axis the lower the correlation between the groups, in figure 4 there is an
obvious high correlation between the means of expression values for genes in the cases of
Cirrhosis and Cirrhosis with HCC. Yet, the HCC samples showed to be more closely correlated
to Cirrhosis Samples and not Cirrhosis HCC. Normal tissue samples showed the least correlation
between Cirrhosis samples and Cirrhosis HCC samples, and showed more of a correlation with
HCC samples in the mean expression values of genes.
In order to further analyze the differential expression in each of the four sample clusters, they
were compared against one another in the fore mentioned 6 groups; (normal_cirrhosis,
normal_cirrhosis

HCC,

normal_HCC,

cirrhosis_cirrhosisHCC,

cirrhosis_HCC,

cirrhosisHCC_HCC). For each group, a scattered plot and a volcano plot were generated using R
studio. Afterwards, the differentially expressed genes were used to create transcription regulatory
networks with their corresponding transcription factors and miRNAs.
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Group 1 (Normal_ Cirrhosis)
Since, each matrix corresponds to the expression values in RMA format obtained from
each sample cluster, each matrix was analyzed against normal samples and a scatter plot was
produced. In figure 5A each gene has an expression value which corresponds to a specific circle
in the plot; those circles that are away from the red line correspond to genes that are
differentially expressed. In order to further analyze these samples for biological and statistical
significance a volcano plot was produced.

Figure 5: (A) Scatter plot of means of expression values for each gene in Normal group and Cirrhosis group. Each circle
expresses an expression value for a gene; those circles that are found close to the red line are not differentially expressed genes
while circles expressing values for genes away from the red line are differentially expressed genes. (B)Volcano Plot expresses the
means of expression values for genes in the Normal_Cirrhosis group. The fold cut off was at value of 2 and the p-value that was
used was 0.01. Circles representing expression values for genes in both groups (normal and cirrhosis) that are found away from
the volcano represent both statistical and biological significance and are further filtered out.

In figure 5B the expression values of genes are plotted against –log p-value and fold
change. In order to analyze for those genes whose expression values are not only biologically
relevant but statistically relevant as well. In figure 3B those circles on the right of the red line
and above the green line have statistical and biological significance and are upregulated as well;
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while those genes whose expression values lie to the left of the blue line and above the green line
show to be both statistically and biologically significant and downregulated as well.
These filtered genes that are shown to have both biological and statistical significance were
determined and further analyzed for their corresponding regulating transcription factors as well
as miRNAs. In order to further analyze the factors that affect differentially expressed genes
between normal tissue samples and cirrhotic tissue samples with HCV infection transcription
factors for differentially expressed genes were determined using a series of databases and online
resources. These transcription factors were further assessed for their frequency in regulating all
of the differentially expressed genes in the group. In the Normal_Cirrhosis group 12 transcription
factors were found to regulate differentially expressed genes most frequently. These transcription
factors include AML1a, AP-1, ATF-2, c-Jun, CREB, C/ebpalpha, HNF-1, HNF-4alpha, PPARgamma, STAT3, STAT5, and NF-Kẞ. In figure 6 a network was constructed showing those
transcription factors and the differentially expressed genes that they regulate.
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Figure 6: Network visualization of transcription factors that were found to be the most common in regulation of differentially
expressed genes in Group Normal_Cirrhosis. The blue circles represent differentially expressed genes and their respective size is
representative of their fold change value. The green circles represent the transcription factors that are regulating their respective
differentially expressed genes.

Another database was used in order to determine miRNAs that regulate differentially expressed
genes. This allowed for an annotation of differentially expressed genes with the miRNAs that
regulate them. A plethora of potential miRNAs were found to regulate genes in this group and
due to the plethora of miRNA that are naturally found in the liver, miRNAs that were chosen for
further analysis were those that showed greatest expression pattern of genes that they regulated
in the group. Also, a review of the literature made it possible to determine the type of regulation
of these miRNAs observed in the presence of HCC. In the table 2 it becomes apparent that the
majority of the miRNAs that are involved in regulation of differentially expressed genes are
downregulated in the presence of HCC. The miRNAs in the table 2 were constructed in a
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network as a visualization of the genes that are involved with these miRNAs. In figure 7 it
becomes apparent that miRNAs are involved in the regulation of a vast array of genes.
Table 2: Differentially expressed genes annotated with their potential miRNAs were analyzed for expression patterns of
miRNAs. The miRNAs reported in this table showed the highest expression patterns for differentially expressed genes in all 6
groups reported previously. The majority of these miRNAs were found to be down regulated in the presence of HCC.

miRNAs with highest Expression Patterns
Regulation
in
miRNA
HCV-HCC
Reference
miRNA-335-5p
Up
(53)
miRNA-128
UP
(54)
miRNA-27 a&b
Down
(55)
miRNA-106a
Down
(55)
miRNA-15a
Down
(55)
miRNA-181 a&c UP
(55)
miRNA-93
Up
(55)
Let-7
Down
(56)
miRNA-199a-3p
Down
(56)
miRNA-124
miRNA-124-3p
miRNA-29 a&c

Down
Down
Down

(57)
(57)
(57)

miRNA-26b-5p
miRNA-200 a&b
miRNA-607

Down
Down
?

(58)
(58)
none
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Figure 7: Network visualization of most common miRNAs regulating differentially expressed genes in group
(Normal_Cirrhosis). The blue circles represent differentially expressed genes and their respective size is representative of their
fold change value. The red circles represent the miRNAs that are regulating their respective differentially expressed genes.

Group 2 Normal_Cirrhosis HCC
The expression values in RMA format obtained from Normal sample cluster were analyzed
against Cirrhosis HCC samples and a scatter plot was produced. In figure 8A, each gene has an
expression value which corresponds to a specific circle in the plot. Those circles that are away
from the red line correspond to genes that are differentially expressed. In the case of normal and
cirrhosis HCC the majority of the differentially expressed genes are found below the red line.
The scatter plot only indicates that there are differentially expressed genes, yet to test whether
these genes are statistically and biologically significant a volcano plot was employed.
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Figure 8: (A) Scatter plot of means of expression values for each gene in Normal group and Cirrhosis HCC group. Each circle
expresses an expression value for a gene; those circles that are found close to the red line are not differentially expressed genes
while circles expressing values for genes away from the red line are differentially expressed genes. (B) Volcano Plot expresses
the means of expression values for genes in the Normal_Cirrhosis HCC group. The fold cut off was at value of 2 and the p-value
that was used was 0.01. Circles representing expression values for genes in both groups (normal and cirrhosis HCC) that are
found away from the volcano represent both statistical and biological significance and are further filtered out

The volcano plot in figure 8B, displays the mean expression values for genes in both normal and
cirrhosis HCC plotted against –log(p-value) and fold change. The fold cutoff for this analysis
was 2 while the p-value was 0.01, however the –log(p-value) was plotted so that positive whole
numbers were obtained and plotted. Here the majority of the genes with both biological and
statistical significance lie to the right and left of the red and blue line, respectively. These genes
were further filtered out in order to determine the transcription factors that facilitate their
regulation.
Differentially expressed genes that were found to have both biological and statistical significance
that had been filtered out, were further annotated with their respective transcription factors.
Using different databases transcription factors were analyzed for a common expression pattern in
their

regulation

of

transcription

amongst

differentially

expressed

genes

in

Normal_CirrhosisHCC. Twelve transcription factors were found; AML1a, AP-1, ATF-2, c-Jun,
CREB, C/ebpalpha, HNF-1, HNF-4alpha, PPAR-gamma, STAT3, STAT5, and NF-Kẞ. In figure
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9 a network was constructed to show the transcription factors and the differentially expressed
genes that they regulate.

Figure 9: Network visualization of transcription factors that were found to be the most common in regulation of differentially
expressed genes in Group Normal_Cirrhosis HCC. The blue circles represent differentially expressed genes and their respective
size is representative of their fold change value. The green circles represent the transcription factors that are regulating their
respective differentially expressed genes.

Another database was used in order to determine miRNAs that regulate differentially expressed
genes. This allowed for an annotation of differentially expressed genes with the miRNAs that
regulate them. A plethora of potential miRNAs were found to regulate genes in this group and
due to the plethora of miRNA that are naturally found in the liver, miRNAs that were chosen for
further analysis were those that showed greatest expression pattern of genes that they regulated
in the group. Also, a review of the literature made it possible to determine the type of regulation
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of these miRNAs observed in the presence of HCC. The network visualization in figure 10
shows the miRNAs that had the greatest expression pattern of regulation of genes in the group.

Figure 10: Network visualization of most common miRNAs regulating differentially expressed genes in group
(Normal_Cirrhosis HCC). The blue circles represent differentially expressed genes and their respective size is representative of
their fold change value. The red circles represent the miRNAs that are regulating their respective differentially expressed genes.

Group 3 Normal_ HCC
For group 3 a pairwise comparison for normal sample cluster was analyzed against HCC
samples and a scatter plot was produced. In figure 11A, each gene has an expression value which
corresponds to a specific circle in the plot. Those circles that are away from the red line
correspond to genes that are differentially expressed. In the case of normal and HCC the
majority of the differentially expressed genes are found below the red line. The scatter plot only
indicates that there are differentially expressed genes, yet to test whether these genes are
statistically and biologically significant a volcano plot was employed.

45

Figure 11: (A) Scatter plot of means of expression values for each gene in Normal group and HCC group. Each circle expresses
an expression value for a gene; those circles that are found close to the red line are not differentially expressed genes while
circles expressing values for genes away from the red line are differentially expressed genes. (B) Volcano Plot expresses the
means of expression values for genes in the Normal_ HCC group. The fold cut off was at value of 2 and the p-value that was used
was 0.01. Circles representing expression values for genes in both groups (normal and HCC) that are found away from the
volcano represent both statistical and biological significance and are further filtered out.

The volcano plot in figure 11B displays the mean expression values for genes in both normal and
HCC plotted against –log (p-value) and fold change. The fold cutoff for this analysis was 2 while
the p-value was 0.01, however the –log (p-value) was plotted so that positive whole numbers
were obtained and plotted. Here the majority of the genes with both biological and statistical
significance lie to the right and left of the red and blue line, respectively. These genes were
further filtered out in order to determine the transcription factors that facilitate their regulation.
Differentially expressed genes that were found to have both biological and statistical significance
that had been filtered out, were further annotated with their respective transcription factors.
Using different databases these transcription factors were analyzed for a common expression
pattern in their regulation of transcription amongst differentially expressed genes in
Normal_HCC. Twelve transcription factors were found; AML1a, AP-1, ATF-2, c-Jun, CREB,
C/ebpalpha, HNF-1, HNF-4alpha, PPAR-gamma, STAT3, STAT5, and NF-Kẞ. In figure 12 a
network was constructed to show those transcription factors and the differentially expressed
genes that they regulate.
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Figure 12: Network visualization of transcription factors that were found to be the most common in regulation of differentially
expressed genes in Group Normal_ HCC. The blue circles represent differentially expressed genes and their respective size is
representative of their fold change value. The green circles represent the transcription factors that are regulating their respective
differentially expressed genes.

Another database was used in order to determine miRNAs that regulate differentially expressed
genes. This allowed for an annotation of differentially expressed genes with the miRNAs that
regulate them. MiRNAs that were chosen for further analysis were those that showed greatest
expression pattern of genes that they regulated in the group. In figure 13, a network visualization
shows the miRNAs that had the greatest expression pattern of regulation of genes in the group.
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Figure 13: Network visualization of most common miRNAs regulating differentially expressed genes in group (Normal_ HCC).
The blue circles represent differentially expressed genes and their respective size is representative of their fold change value. The
red circles represent the miRNAs that are regulating their respective differentially expressed genes.

Group 4 Cirrhosis_ Cirrhosis HCC
In order to analyze how transcription regulation is influenced in stages to carcinoma each
samples’ clusters were analyzed in three groups the first of which cirrhosis_ cirrhosis HCC.
Here, the expression values in RMA format obtained from cirrhosis sample cluster were
analyzed against cirrhosis HCC samples and a scatter plot was produced. In figure 14A, each
gene has an expression value which corresponds to a specific circle in the plot. Those circles that
are away from the red line correspond to genes that are differentially expressed. In the case of
cirrhosis and cirrhosis HCC the majority of the differentially expressed genes are found close to
the red line with only a few scattered circles away from the red line. The scatter plot only
indicates that there are differentially expressed genes, yet to test whether these genes are
statistically and biologically significant a volcano plot was employed.
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Figure 14: (A) Scatter plot of means of expression values for each gene in cirrhosis group and cirrhosis HCC group. Each circle
expresses an expression value for a gene; those circles that are found close to the red line are not differentially expressed genes
while circles expressing values for genes away from the red line are differentially expressed genes. (B) Volcano Plot expresses
the means of expression values for genes in the cirrhosis_ cirrhosis HCC group. The fold cut off was at value of 0.75 and the pvalue that was used was 0.01. Circles representing expression values for genes in both groups (cirrhosis and cirrhosis HCC) that
are found away from the volcano represent both statistical and biological significance and are further filtered out.

The volcano plot in figure 14B, displays the mean expression values for genes in both cirrhosis
and cirrhosis HCC plotted against –log (p-value) and fold change. The fold cutoff for this
analysis was 0.75 while the p-value was 0.01, however the –log (p-value) was plotted so that
positive whole numbers were obtained and plotted. Here the majority of the genes with both
biological and statistical significance are upregulated and lie to the right and left of the red and
blue line, respectively and above the green line. Those circles that lie to the right and left of the
red and blue line and below the green line are down regulated. These genes were further filtered
out in order to determine the transcription factors that facilitate their regulation.
Differentially expressed genes that were found to have both biological and statistical significance
that had been filtered out, were further annotated with their respective transcription factors.
Using different databases these transcription factors were analyzed for a common expression
pattern in their regulation of transcription amongst differentially expressed genes in cirrhosis_
cirrhosis HCC. Twelve transcription factors were found; AML1a, AP-1, ATF-2, c-Jun, CREB,
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C/ebpalpha, HNF-1, HNF-4alpha, PPAR-gamma, STAT3, STAT5, and NF-Kẞ. In figure 15, is a
network showing those transcription factors and the differentially expressed genes that they
regulate.

Figure 15: Network visualization of transcription factors that were found to be the most common in regulation of differentially
expressed genes in group cirrhosis_ cirrhosis HCC. The blue circles represent differentially expressed genes and their respective
size is representative of their fold change value. The green circles represent the transcription factors that are regulating their
respective differentially expressed genes.

Another database was used in order to determine miRNAs that regulate differentially expressed
genes. This allowed for an annotation of differentially expressed genes with the miRNAs that
regulate them. MiRNAs that were chosen for further analysis were those that showed greatest
expression pattern of genes that they regulated in the group. Also, a review of the literature made
it possible to determine the type of regulation of these miRNAs observed in the presence of
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HCC. The network visualization in figure 16, shows the miRNAs that had the greatest expression
pattern of regulation of genes in the group.

Figure 16: Network visualization of most common miRNAs regulating differentially expressed genes in group
(cirrhosis_cirrhosis HCC). The blue circles represent differentially expressed genes and their respective size is representative of
their fold change value. The red circles represent the miRNAs that are regulating their respective differentially expressed genes.

Group 5 Cirrhosis_HCC
Here, the expression values in RMA format obtained from cirrhosis sample cluster were
analyzed against HCC samples and a scatter plot was produced. Each gene has an expression
value which corresponds to a specific circle in the plot. Those circles that are away from the red
line correspond to genes that are differentially expressed as shown in figure 17A. In the case of
cirrhosis and HCC the majority of the differentially expressed genes are found close to the red
line with only a few scattered circles away from the red line. The scatter plot in figure 17A, only
indicates that there are differentially expressed genes, yet to test whether these genes are
statistically and biologically significant a volcano plot was employed.

51

Figure 17: (A) Scatter plot of means of expression values for each gene in cirrhosis group and HCC group. Each circle expresses
an expression value for a gene; those circles that are found close to the red line are not differentially expressed genes while
circles expressing values for genes away from the red line are differentially expressed genes. (B) Volcano Plot expresses the
means of expression values for genes in the cirrhosis_HCC group. The fold cut off was at value of 0.75 and the p-value that was
used was 0.01. Circles representing expression values for genes in both groups (cirrhosis and HCC) that are found away from the
volcano represent both statistical and biological significance and are further filtered out.

The volcano plot in figure 17B displays the mean expression values for genes in both cirrhosis
and HCC plotted against –log (p-value) and fold change. The fold cutoff for this analysis was
0.75 while the p-value was 0.01, however the –log (p-value) was plotted so that positive whole
numbers were obtained and plotted. Here the majority of the genes with both biological and
statistical significance are upregulated and lie to the right and left of the red and blue line,
respectively and above the green line. Those circles that lie to the right and left of the red and
blue line and below the green line are down regulated. These genes were further filtered out in
order to determine the transcription factors that facilitate their regulation.
Differentially expressed genes that were found to have both biological and statistical significance
that had been filtered out, were further annotated with their respective transcription factors.
Using different databases these transcription factors were analyzed for a common expression
pattern in their regulation of transcription amongst differentially expressed genes in
Cirrhosis_HCC. Twelve transcription factors were found; AML1a, AP-1, ATF-2, c-Jun, CREB,
C/ebpalpha, HNF-1, HNF-4alpha, PPAR-gamma, STAT3, STAT5, and NF-Kẞ. In figure 18, is a
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network showing those transcription factors and the differentially expressed genes that they
regulate.

Figure 18: Network visualization of transcription factors that were found to be the most common in regulation of differentially
expressed genes in group cirrhosis_ HCC. The blue circles represent differentially expressed genes and their respective size is
representative of their fold change value. The green circles represent the transcription factors that are regulating their respective
differentially expressed genes.

Another database was used in order to determine miRNAs that regulate differentially expressed
genes. This allowed for an annotation of differentially expressed genes with the miRNAs that
regulate them. A plethora of potential miRNAs were found to regulate genes in this group and
due to the plethora of miRNA that are naturally found in the liver, miRNAs that were chosen for
further analysis were those that showed greatest expression pattern of genes that they regulated
in the group. Also, a review of the literature made it possible to determine the type of regulation
of these miRNAs observed in the presence of HCC. The network visualization in figure 19,
shows the miRNAs that had the greatest expression pattern of regulation of genes in the group.
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Figure 19: Network visualization of most common miRNAs regulating differentially expressed genes in group (cirrhosis_ HCC).
The blue circles represent differentially expressed genes and their respective size is representative of their fold change value. The
red circles represent the miRNAs that are regulating their respective differentially expressed genes.

Group 6 Cirrhosis HCC_ HCC
Expression values in RMA format obtained from cirrhosis HCC sample cluster was analyzed
against HCC sample cluster and a scatter plot was produced. Each gene has an expression value
which corresponds to a specific circle in the plot. Those circles that are away from the red line
correspond to genes that are differentially expressed. In figure 20A, for cirrhosis HCC and HCC
the majority of the differentially expressed genes are found close to the red line with only a few
scattered circles away from the red line. The scatter plot only indicates that there are
differentially expressed genes, yet to test whether these genes are statistically and biologically
significant a volcano plot was employed.
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Figure 20: (A) Scatter plot of means of expression values for each gene in cirrhosis HCC group and HCC group. Each circle
expresses an expression value for a gene; those circles that are found close to the red line are not differentially expressed genes
while circles expressing values for genes away from the red line are differentially expressed genes. (B) Volcano Plot expresses
the means of expression values for genes in the cirrhosis HCC_HCC group. The fold cut off was at value of 1.5 and the p-value
that was used was 0.01. Circles representing expression values for genes in both groups (cirrhosis HCC and HCC) that are found
away from the volcano represent both statistical and biological significance and are further filtered out.

The volcano plot in figure 20B displays the mean expression values for genes in both normal and
HCC plotted against –log (p-value) and fold change. The fold cutoff for this analysis was 1.5
while the p-value was 0.01, however the –log (p-value) was plotted so that positive whole
numbers were obtained and plotted. Here the genes with both biological and statistical
significance are upregulated and lie to the right and left of the red and blue line, respectively and
above the green line. The majority of the circles representing differentially expressed genes
which lie to the right and left of the red and blue line and below the green line are down
regulated. These genes were further filtered out in order to determine the transcription factors
that facilitate their regulation.
Differentially expressed genes that were found to have both biological and statistical significance
that had been filtered out, were further annotated with their respective transcription factors.
Using different databases the transcription factors were analyzed for a common expression
pattern in their regulation of transcription amongst differentially expressed genes in Cirrhosis
HCC_HCC. Twelve transcription factors were found; AML1a, AP-1, ATF-2, c-Jun, CREB,
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C/ebpalpha, HNF-1, HNF-4alpha, PPAR-gamma, STAT3, STAT5, and NF-Kẞ. In figure 21, is a
network showing those transcription factors and the differentially expressed genes that they
regulate.

Figure 21: Network visualization of transcription factors that were found to be the most common in regulation of differentially
expressed genes in group cirrhosis HCC_ HCC. The blue circles represent differentially expressed genes and their respective size
is representative of their fold change value. The green circles represent the transcription factors that are regulating their
respective differentially expressed genes.

Another database was used in order to determine miRNAs that regulate differentially expressed
genes. This allowed for an annotation of differentially expressed genes with the miRNAs that
regulate them. A plethora of potential miRNAs were found to regulate genes in this group and
due to the plethora of miRNA that are naturally found in the liver, miRNAs that were chosen for
further analysis were those that showed greatest expression pattern of genes that they regulated
in the group. Also, a review of the literature made it possible to determine the type of regulation
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of these miRNAs observed in the presence of HCC. The network visualization in figure 22,
shows the miRNAs that had the greatest expression pattern of regulation of genes in the group.

Figure 22: Network visualization of most common miRNAs regulating differentially expressed genes in group (cirrhosis_ HCC).
The blue circles represent differentially expressed genes and their respective size is representative of their fold change value. The
red circles represent the miRNAs that are regulating their respective differentially expressed genes .

In figure 23, the transcription factors with the highest expression in all 6 pairwise combinations
were further analyzed through a systematic analysis of the literature that is present and it was
determined that these transcription factors are involved in regulating HCV induced HCC into
three stages angiogenesis, steatosis, and cancer induction. Also in figure 23, the miRNAs with
the highest expression in all 6 pairwise combinations were analyzed similarly, and it was
determined that the expression of miRNAs decreases as the liver digresses to carcinoma.
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Figure 23: Overview of the transcription factors that regulate HCV induced HCC in each stage as the liver digresses to
eventually becoming carcinomic; and the digression of miRNA expression in liver tissue as they digress to carcinoma.

However, in order to account for the differentially expressed genes that are regulated by the master
regulators that were determined in this study and how they are biologically/ functionally organized
another figure was produced. In figure 24, the differentially expressed regulated by their transcription
factors in each stage in the digression of the liver is displayed so as to demonstrate the overall findings f
this study and to illustrate the actions of all the key players in the transcription regulation of HCVinduced HCC.
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Figure 24: Transcription Regulation HCV-induced HCC. This is an illustration of the master regulators in HCV-induced HCC
and their differentially expressed genes. The key genes and transcription factors associated with each condition of the liver is
illustrated as they were found in each of the 6 pairwise comparisons, also with the general expression of miRNAs as the liver
transitions from one condition to the next.
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Chapter 5. Discussion and Conclusions
I.

Differentially Expressed Genes

In the present study the aim was to identify the transcriptional regulation that gears differentially
expressed genes in the progression of HCV induced HCC. This study highlights the molecular
switches that may be involved in this progression and takes into consideration that transcriptional
regulation is not only controlled by transcription factors but by other regulatory elements such as
miRNAs that may influence the expression of genes. This analysis was conducted based on the
findings of multiple studies, and therefore it must be noted that HCV induced HCC is a results of
a combination of different regulatory elements both mRNA and miRNA in basis.
However, to begin it is vital to understand the differentially expressed genes that underlie this
transcriptional regulation. In this study, after analyzing unique probe sets for every tissue type/
condition it was determined that the gene expression patterns varied significantly among the
HCC and normal liver samples. These findings coincide with the study from which the
microarray samples were attained Mas V.R. and colleagues, whose findings also show that genes
associated with cell proliferation and mitosis had increased expression in HCC samples, while
the genes that were expressed in lower levels were genes that are specifically expressed in
differentiated hepatocytes. (Mas et al., 2009) Also, the findings in the present study coincide
with the findings of Mas V.R. and colleagues for gene expression patterns amongst the 4 various
tissue types/conditions. Yet, the DAVID analysis that was created for each pairwise comparison
in the various tissue types/conditions show that between normal and HCC samples differentially
expressed genes cluster functionally in signaling within the cell with an enrichment score of
9.13. (Figure 25) Again, here it becomes apparent that specificity in the functionality of genes is
no longer present and the main function for differentially expressed genes in the late stage of
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liver disease is signaling. Also, the functionality of the genes does not change amongst the
various pairwise comparisons between normal liver and cirrhosis as well as cirrhosis HCC. In
figure 26 and 27 below it becomes apparent that the primary function of differentially expressed
genes in each pairwise comparison (cirrhosis and cirrhosis HCC) is signaling with an enrichment
score of 13 and 18.31 respectively.

Figure 25: DAVID analysis, functional annotation clustering of differentially expressed genes in the pairwise comparison
between Normal and HCC samples. With an enrichment score of 9.13 the primary cluster is found to be with genes involved in
signaling.
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Figure 26: DAVID analysis, functional annotation clustering of differentially expressed genes in the pairwise comparison
between Normal and cirrhosis samples. With an enrichment score of 13 the primary cluster is found to be with genes involved in
signaling.

Figure 27: DAVID analysis, functional annotation clustering of differentially expressed genes in the pairwise comparison
between Normal and cirrhosis HCC samples. With an enrichment score of 18.31 the primary cluster is found to be with genes
involved in signaling.

Since cirrhosis is an established risk factor for HCC the study by Mas V.R. and colleagues
compared HCV-HCC samples with HCV cirrhosis samples they show that cell adhesion, cell
division, and apoptosis were the more important cellular and molecular functions.(59) They also
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found a lower number of differentially expressed genes in this pairwise comparison. These
findings are similar to the findings of this study in that the DAVID analysis in figures 28, 29, and
30 that was used to compare cirrhosis samples to HCC in the different stages also was able to
find that the primary functional clusters were involved in cell attachment, as well as key words
involved in cell division and apoptosis.

Figure 28: DAVID analysis, functional annotation clustering of differentially expressed genes in the pairwise comparison
between cirrhosis and cirrhosis HCC samples. With an enrichment score of 3.08 the primary cluster is found to be with genes
involved in secretion and cell attachment.
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Figure 29: DAVID analysis, functional annotation clustering of differentially expressed genes in the pairwise comparison
between cirrhosis and HCC samples. With an enrichment score of 2.46 the primary cluster is found to be with genes involved in
secretion and signaling.

Figure 30: DAVID analysis, functional annotation clustering of differentially expressed genes in the pairwise comparison
between HCC and cirrhoisHCC samples. With an enrichment score of 1.23 the primary cluster is found to be with genes involved
in response to stimulus and protein activity.

In this study it was also observed that gene expression related to normal liver function
significantly decreased across tissue types from normal liver, to cirrhosis, to cirrhosis HCC, to
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HCC; which coincides with the findings of (Mas et al., 2009). It was also observed that each
pathological stage in the liver progression to HCC in the presence of HCV infection is marked by
gene signatures; which are dictated by the master regulators that control their expression.
Amongst the main signaling pathways that were found to be prevalent was the JAK/STAT
signaling pathway, which Mas V.R. and his group noted to represent the more important
downregulated canonical pathways. This pathway is one of the primary pathways that once
downregulated tends to induce cancer. (Mas et al., 2009)
The David analysis above for each of the pairwise comparisons coincides with the findings of
Mas V., etal in that there are gene signatures for each pathological tissue type in the progression
to HCC. Gene signatures, are specific sets of genes with a similar biological function with high
expression in each biological tissue type. Biologically, it can be observed that these gene
signatures change from normal to cirrhotic tissue as genes struggle to maintain normal
functioning such as cell adhesion and cell signaling. Then, as the condition of the liver digresses
the gene signatures for cirrhosis HCC and HCC tissues changes as well as cells struggle to stay
alive and therefore genes that are more prevalent are those involved in proliferation and
apoptosis. It is also important to note that differentially expressed genes in each pairwise
comparison show a progression of the condition of the liver. As the condition of the liver
progresses to carcinoma the regulation of these genes is determined not only by the condition of
the liver but also by the presence of regulatory elements underlying the command of that gene
and in turn controlling the final state of the liver. These regulatory elements are transcription
factors and miRNAs that underlie the switching on/off of these genes and in turn controlling the
molecular biology of the condition of the liver as it progresses to HCC.

65

II.

Transcription Factors

As HCV infection aggregates more and more within the liver, the condition of the liver
worseness. As the liver digresses from a cirrhotic liver, to steatosis of the liver, and eventually
becoming cancerous. Although, this sequence of events is not dogma and the liver may digress
from any one of these conditions directly to carcinoma, if the attributes that satisfy the conditions
for each event are present the liver will digress in this sequence and eventually become
carcinomic. Each one of these conditions entails a different molecular key switch as different
genes are turned on and off to substitute for the digressing functionality of the liver. As
previously noted in each of the pairwise comparisons of the liver it was found that cell signaling
as well as other important cellular functions were of the most common functionalities effected as
the condition of the liver digresses from normal to cancerous in the presence of HCV infection. It
is important to note that also of the keywords that arise in the functional annotation clustering
tool (DAVID) is the keyword “fat”; this also is of value in that it shows that the functionality of
the differentially expressed genes is also linked to lipid metabolism.
HCV infection relies heavily on lipid metabolism in the liver for viral entry and replication.
Assembly of HCV virion is brought about by the synchronized actions of HCV structural
proteins along with the viral replication complex, and takes place in close proximity to
membrane bound lipid droplets (LD). Lipid droplets (LDs) are intracellular organelles storing
cholesterol and triglycerides, and play an essential role in viral packaging. Inhibition of the
synthesis of their lipid components blocks viral assembly. In the blood HCV virions circulate as
lipo-viro-particles (LVPs) which are found to be associated with very low or low-density
lipoproteins (VLDLs and LDLs). These LVPs may also associate with high levels of
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triglycerides, Apolipoprotein (Apo) E, ApoC, ApoB and low levels of cholesterol or
phospholipids (17). This HCV virion association with lipids may facilitate its infection of
hepatocytes which are the primary target for infection while at the same time aiding in its escape
from neutralizing antibodies. (18) This in turn would explain the association between
differentially expressed genes and the keyword FAT in the functional annotation clustering of
genes.
Annotation of the differentially expressed genes with their respective transcription factors
coincides with the functional annotation of the differentially expressed genes in that it was found
that main transcription factors involved in regulation of the differentially expressed genes were
marked by 3 hepatic conditions; hepatic angiogenesis, hepatic steatosis, and hepatic carcinoma.
In figure 4 above it becomes apparent that many genes involved in normal liver function are
being regulated by the transcription factors involved in each hepatic condition. However as the
number of genes in normal liver function decreases the master transcriptional regulators dictate
the expression of specific genes involved in other pathways such as cell proliferation this is
observed in figure 7, 10, 13, 16, and 19. Each one of these hepatic conditions calls upon a
different key switch of genes and transcription factors however, it explains the digression of the
liver to carcinoma and foretells the possible points at which molecular intervention may be key
to stop this digression and possibly save the liver or freeze it in its current state.
a. Hepatic Angiogenesis
Angiogenesis and the disruption of liver vascular architecture have been linked to progression to
cirrhosis and liver cancer (HCC) in chronic liver diseases, which contributes both to increased
hepatic vascular resistance and portal hypertension and to decreased hepatocyte perfusion. (60)
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Angiogenesis was also found to be important in adult tissue repair. (61)In the present study, 5
main transcription factors were determined to have a common expression pattern amongst all 6
pairwise comparisons. These 5 transcription factors may be the key switches in the effect of
transcriptional regulation of differentially expressed genes; AP-1, C-JUN, AML1, CREB, and
ATF-2. From the literature it was apparent that these 5 transcription factors regulate genes that
are involved in hepatic angiogenesis.
Angiogenesis is implicated in cancer development by favoring progression, growth, and
metastasis of cancer and is regulated by growth factors, including transforming growth factorbeta (TGF-ẞ), basic ﬁbroblast growth factor, or platelet-derived growth factor. In tumor cells
induction of hepatic angiogenesis during chronic HCV infection may contribute to the early
development of cancer cells. (62)
One of the 5 transcription factors acute myelogenous leukemia 1 (AML1)/runt-related
transcription factor 1 (Runx1) belongs to a family of transcriptional regulators called Runx.
Gene-targeting studies in mice have demonstrated that AML1 is essential for early development
of deﬁnitive hematopoiesis. (63) A study by Takakura and colleagues was able to show that
AMl1 deficient embryos lack definitive hematopoiesis and thus show defective angiogenesis in
the head and pericardium. (61) In a study by Hassan M. and colleagues the mechanistic role of
HCV core protein is better understood as they provide evidence for its role in the regulation of
hepatic angiogenesis during the course of HCV infection and demonstrate its ability to trigger the
production of both TGF-ẞ2 and VEGF proteins by multiple pathways including PKC, RB/E2F1,
ASK1-JNK/p38, and ERK. These pathways include transcription factors that were found to be
the main transcription regulators of differentially expressed genes. (62) Of these pathways, the
PKC pathway was found to turn on CREB and ATF-2, while ASK1-JNK/p38 was found to
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control AP-1. AP-1 is an important target for the JNK signaling pathway and is composed of Jun
, Fos, and related bZIP subunit. (64)
As the liver vascular architecture changes and the liver proceeds in the direction of fibrosis
another condition starts to develop as well; hepatic steatosis. This condition may be in part as a
reaction to the changes that are already taking place in the liver as the liver may call upon lipids
for the increasing viral particles and replication that is present due to HCV infection. Rutkowski
D.T. and colleagues suggest that one of the possible reasons behind steatosis is the suppression
of a subset of metabolic transcription factors that regulate lipid homeostasis as a direct response
to ER homeostasis.(65) The exact mechanism of this digression from hepatic angiogenesis to
hepatic steatosis is unknown, however it is apparent that each condition hampers the
functionality of the liver leading to carcinoma.
b. Hepatic Steatosis
Hepatic steatosis is common amongst patients with HCV as HCV core protein play an important
role in the development of hepatic steatosis in HCV infection. HCV core protein has an elevated
effect on the transcriptional activity of PPARγ (peroxisome proliferators-activated receptor γ).
This transcription factor, PPARγ as well as HNF1, HNF4, and C/EBPα were found to be
amongst the transcription factors with the highest expression patterns regulating differentially
expressed genes in each of the 6 pairwise comparisons involved in this study.
PPARγ is a master regulator for adipocyte differentiation and is important in the regulation of a
number of genes involved in fatty acid and glucose metabolism. Thus down regulation of liver
PPARγ which contributes to regulation of lipid synthesis, transport, and storage within
hepatocytes, causes the development of hepatic steatosis.(66) CCAAT/enhancer-binding protein
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alpha (C/ebpα) another transcriptional regulator found to have high expression pattern in
differentially expressed genes has been shown to be involved in regulating gluconeogenesis and
lipogenesis while being downregulated in response to hepatic steatosis.
Hepatocyte nuclear factors 1 and 4 (HNF1 and HNF4) are a group of transcription factors that
are involved with glucose, cholesterol, and fatty acid transport and metabolism. HCV induces
HNF1 and HNF4 due to increased oxidative stress and direct protein-protein interactions
between HCV non-structural component (NS) 5A and HNF1. Again, some HCV proteins,
particularly the structural capsid protein, core, and the non-structural protein, NS5A, can induce
hepatic steatosis by interfering with intracellular lipid metabolism. (67) Alteration of expression
of these genes might be related to abnormal expression of metabolic enzymes again leading to
hepatic steatosis. (68)
Univariate and multivariate analyses identified hepatic steatosis, together with aging, cirrhosis,
and lack of IFN treatment, as significant independent risk factors for HCC. Several studies have
revealed that hepatic steatosis, including steatosis induced by HCV core protein, predisposes to
lipid peroxidation and excess free-radical activity with the potential risk of genomic mutations.
Hepatic steatosis is an independent risk factor for HCC in patients with chronic HCV infection,
although the factors responsible for steatosis could not be identified clearly. (69)

c. Cancer Induction
The production of a great number of cytokines, chemokines and growth factors, favoring
increased cellular proliferation accompany the continuous cell death and inflammatory cell
infiltration during cancer development. This continuing hepatocyte death triggers liver repair and
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regeneration and eventually leads to severe liver fibrosis or cirrhosis. Multiple signaling
pathways are involved in this injury-inflammation-regeneration response and in human HCC
development. In the present study 3 transcription factors were found to have high expression
patterns amongst all 6 pairwise comparisons as a result of prolonged HCV infection; these
transcription factors include NF-κB, STAT3, and STAT 5.

Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is a protein complex that
regulates cell survival, immunity and inflammation, and is one of the more important pathways
that is activated during liver injury and inflammation. One of the main functions of NF-κB in
hepatocytes appears to be the production of cytokines that maintain the inflammatory
microenvironment in which tumors develop.(70)

Signal transducer and activator of transcription 3 (STAT3) is another transcriptional factor
involved in immune responses, inflammation and tumorigenesis, and was found to be critical for
compensatory liver regeneration and chemically-induced HCC development. STAT3 belongs to
the signal transducer and activator of transcription (STAT) family. Like its relatives, STAT3 is
inactive in non-stimulated cells, but is rapidly activated by various cytokines and growth factors,
such as IL-6 and EGF family members, as well as hepatocyte growth factor (HGF) STAT3 in
cancer cells is activated by cytokines and growth factors that are produced within the tumor
microenvironment. The expression of IL-6, one of the major STAT3-activating cytokines, and is
elevated in human liver diseases and HCC. (71)
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Signal transducer and activator of transcription 5 (STAT5) proteins are involved in cytosolic
signaling and in mediating the expression of specific genes. While STAT5 activation plays an
important role in promoting tumorigenesis via the upregulation of anti-apoptotic, cell
proliferative, and invasion of metastasis-related genes. (71)

III. miRNAs
The molecular mechanisms underlying transcriptional regulation of miRNA genes in the liver
remain largely unknown. Whether transcription factors are also involved in the transcriptional
regulation of miRNAs in the liver is unclear since the functional expression of transcription
factors can also be regulated by miRNAs. Yet, it is clear that miRNAs can potentially regulate
every aspect of cellular activity and a diverse spectrum of liver functions. (54)

In the present study it was observed that each tissue type or condition had its own respective
signature miRNA pattern, however there was a commonality amongst all 6 pairwise comparisons
that were analyzed as shown in the table 1. As was observed for the expression of genes
regulated by the master transcription factors involved in each hepatic condition, the number of
genes that are regulated by miRNAs decrease as the number of genes involved in normal liver
function decreased. This can be observed in the networks above in figures 8, 11, 14, 17 and 20.
However unlike transcription factors miRNAs did not show a functional relationship between the
genes that they regulate; again this expresses the specificity by which miRNAs regulate the
expression of genes. In table 2 the miRNAs that had the highest expression were annotated with
their predicted differentially expressed target genes in all 6 pairwise comparisons. After analysis
using functional annotation clustering it becomes apparent that the differentially expressed genes
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that miRNAs regulate are involved in maintaining cellular homeostasis and the up keeping of fat
metabolism. Therefore, as cellular homeostasis becomes imbalanced and fat metabolism is
disrupted the expression of miRNAs decreases as the liver digresses to carcinoma.
Table 3: The miRNAs with the highest expression in all 6 pairwise combinations were annotated with their differentially
expressed target genes.

miRNAs
Let-7
miR-124-3p
miR-124
miR-29a
miR-29c
miR-26b-5p

miR-335-5p
miR-27a&b
miR-106a
miR-128
miR-15a
miR-181a
miR-181c
miR-199a-3p
miR-200a
miR-200b
miR-93
miR-607

Predicted Target Genes
THBS1, COL1A2, COL1A1, DKK3, ADAMTS1, KLF9
HLA-DPB1, COL4A1, TNFRSF21, CTGF, RAPGEF5, CALR, EMP1,
IGFBP7, SNAI2, VIM, F3, KLF4, EMP1, IFI44L, MFAP4, RBPMS
ANK3, AQP1, VCAN, VIM, THBD, KLF9, GATA6, ZBTB43, CEBPA
LAMA2, EMP1, PDK4, COL1A2, COL1A1, CXCL12, ENG, CYR61,
RAB20, MGAT4B
LAMA2, COL1A2, COL1A1, COL6A2, LAMA2, MGAT4B
GEM, ITM2A, MGP, FBLN5, CXCL9, GPR183, ARL4C, LYZ, PDK4,
GPR183, F3, CCL2, PDGFRA, TRIM22, VIM, TAGLN, FABP4, IFI44L,
VIM, ARL4C, IL7R
TRIM22, PDK4, SOX9, PTGDS, CRISPLD2, CXCL9,
PPP1R1A,TACSTD2, MGP, CCL20, FABP4, GEM, FBLN5, AREG,
PLAT, EMP1, SEL1L3, KCTD12, SOX4, ID4, SH3YL1,
ST3GAL6, FBLN5, RGS1, LHFP, F3
ARL4C, FZD7, PDGFRA, TXNIP, F3, CD69, CELF2, ANKRD12,
TMEM100, CD69, MCL1, IL6ST,PIK3R1,PDGFRA, UBE2W,
ZBTB43, PTPN4, MCL, BBX, SLC4A4
PDGFRA, KLF4, APOLD1, UBE2W, PDGFRA, RAB20, MGAT4B
TXNIP, PDK4, CD69, EIF4B,TMEM100, ADAMTS1, HNRNPA1, ADAMTS1,
SLC4A4, PIK3R1
CD69, VCAN, SPP1, EVI2A
CYR61, HSP90B1, ADM, CALR, SLA
PDGFRA, CELF2, CXCL12, FGL2, CD44, KRT7, ZBTB43, PIK3R1, UBE2W,
FOS
APOLD1, GATA6,
LHFP, ANK3, GEM, ADAMTSL2, KLF4, GPM6A, ZBTB38,
F3, CD69, FZD7, TGFB1I1, VIM, MCL1, BBX, SLC4A4, PTPN4
FZD7, IGJ, FGL2, CXCL12, LHFP, GJA1

Of the miRNAs that were found to be downregulated miR-27, miR-199, miR-200, and let-7
family members were amongst them and were found to target genes involved in cell cycle and
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cell death regulation.(53) These miRNAs were also found in this study to have high expression
in normal liver tissue and eventually no expression in carcinoma tissue with HCV infection.
Downregulation of the miRNAs miR-26, miR-29, and miR-124 have been implicated in cell
proliferation, apoptosis, angiogenesis, and poor prognosis.(58) In a previous study, a correlation
between miR-106a and the degree of differentiation was shown to suggest an involvement of
specific miRNAs in the progression of the disease.(54) Lee and colleagues provide data to
support the down-regulation of miRNA miR15a and increased cellular proliferation. (58)

MiRNAs that were found to be upregulated were miRNA-335-5p, miR-93, miR-181a & c, and
miR-128. MiRNA-335-5p was found to be associated with non-alcoholic fatty liver disease and
also showed a connection with metabolic disorders. (53) MiR-93 is overexpressed in HCC and
may have a critical role in cell proliferation by regulating the G1-to-S cell cycle transition. (53)
MiR-181 is upregulated and promotes migration and invasion of HCC cells.(56) The upregulated miR-128, has nearly perfect complementarity in its seed sequences with HCV RNA
genomes and is capable of inhibiting HCV replication and infection.(54)
As for miR-607 while it was of the miRNAs with high expression patterns for differentially
expressed genes there was no information in the literature to date as to how it influences the
digression in the condition of the liver or even how it regulates genes in the development of HCC
in the liver. However, it can be noted that mIR-607 does act as a tumor suppressor in other
cancers, such as male breast cancer.

IV. Conclusions
Transcriptional regulation of HCV-induced HCC is very complex in that it encompasses a wide
variety of aspects as the liver travels from condition to condition in its progression to HCC. In
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this study the aim was to focus on determining high expression patterns in transcriptional
regulation of differentially expressed genes that are common in all 6 pairwise comparisons so as
to outline the transcriptional regulation that underlies each condition in HCV-induced HCC.
These master regulators in each condition may explain the underlying molecular mechanisms
and signaling pathways that are influenced by the progression of liver disease. As was discussed
above, the PKC pathway was found to turn on CREB and ATF-2, while ASK1-JNK/p38 was
found to control AP-1 which is composed of Jun, Fos in hepatic angiogenesis. While in hepatic
steatosis, master transcriptional regulators were found to manipulate metabolic enzymes that
drastically change in the condition of the liver. In the progression to cancer, it seems that IKK
dependent signaling as well as JAK-STAT pathway are the major contributors to the final stages
of liver disease as cell proliferation and apoptosis provide the means for complete progression to
HCC.
Also, one of the major contributors in the progression of liver disease is the impact of miRNAs
on transcriptional regulation again as was discussed above it is unclear whether transcription
factors are also involved in the transcriptional regulation of miRNAs in the liver since the
functional expression of transcription factors can also be regulated by miRNAs. Yet, it is clear
that miRNAs can potentially regulate every aspect of cellular activity and a diverse spectrum of
liver functions.(54) In this study it was apparent that there are a plethora of miRNAs that
underlie the control of cellular homeostasis in the liver. It was also apparent that each liver
condition had its signature expression pattern of miRNAs. Yet, the miRNAs that were found to
have high expression patterns in all 6 pairwise comparisons were shown to be master regulators
in transcriptional regulation and in turn having an impact on the conditions of the liver and the
progression to HCC.
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Chapter 6. Future Directions
Understanding the molecular mechanisms that underlie the influence HCV has on the
progression to HCC is of vital importance in that it aids in the ability to create a more precise
treatment regime with the least amount of negative impact on the patient. In the present study
our aim was to determine transcriptional regulatory networks in HCV-induced HCC. Here we
were able to determine master transcriptional regulators that dictate each stage in the progression
to HCC with HCV infection. In the future we strive to accomplish 4 major objectives.

Objective 1
Determine the signature transcription factors with high expression patterns in each
condition and the genes that they influence for a more honed understanding of the
underlying molecular mechanism that influences cellular homeostasis in each stage of
liver disease. This would also provide insight as to the possible signaling pathways that
may be manipulated for stopping the progression of liver disease.

Objective 2
Determine the signature miRNAs with high expression patterns in each condition and the
genes that they influence for a more honed understanding of the underlying molecular
mechanism that influences cellular homeostasis in each stage of liver disease. This would
also provide insight as to the possible signaling pathways that also may be manipulated
for stopping the progression of liver disease.

Objective 3
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Determine

whether

transcription

factors

and

miRNAs

effect

one

another

transcriptionally; and the influence this may have on differentially expressed genes in
HCV-induced HCC and the progression of liver disease.

Objective 4
Determine specific transcription factors in conjunction with its specific miRNAs that
influence transcription regulation together in order to provide a mechanistic tool that may
be produced in order to give a better treatment option for HCV patients and stop the
progression of the liver to HCC.
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